August 2, 2023 PERSONAL AND CONFIDENTIAL BY EMAIL Senthil Sundaram Dear Sen:Terns Pharmaceuticals, Inc. • November 14th, 2023 • Pharmaceutical preparations • California
The purpose of this separation agreement (the “Agreement”) is to confirm the terms of your transition from CEO of Terns Pharmaceuticals, Inc. and any affiliates, including without limitation, Terns, Inc. (collectively, the “Company”), pursuant to your Employment Agreement, dated and amended as of November 8, 2022 (the “Employment Agreement”). This Agreement outlines the terms of certain benefits and payments to you in connection with your transition and termination.
